课题基金 / 基金详情

Sulfhydryl Cross-linked Targeted Gene Delivery

Sulfhydryl Cross-linked Targeted Gene Delivery
巯基交联靶向基因递送
批准号:
6995363
负责人:
KEVIN G RICE
金额:
$21.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-01 至 2008-05-30

项目摘要

项目成果

KEVIN G RICE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This study will investigate a novel gene delivery system that is based on the formation of sulfhydryl crosslinks within peptide DNA condensates. The gene delivery system under investigation is a multi-component peptide condensed DNA formulation. The key components consist of plasmid DNA condensed by an addmixture of peptide conjugates each containing multiple sulfhydryl groups designed to spontaneously polymerize and cross-link when bound to DNA. Following i.v. dosing, cross-linked DNA condensates are proposed to transiently stabilize plasmid DNA during circulation and inside the target cells. Cross-linking peptides will be covalently derivatized with a single polyethylene glycol (PEG) chain to form a steric layer on the surface of DNA condensates that blocks protein binding and masks DNA condensate recognition by the reticuloendothelial system. Targeting specificity will be achieved by derivatizing a cross-linking peptide with a single N-glycan resulting in glycopeptides that direct targeting to either the asialoglycoprotein receptor on hepatocytes or the mannose receptor on Kupffer cells. DNA condensates will be prepared using binary addmixtures of cross-linking glycopeptide and PEG-peptide. Cross-linking peptides will be modified to buffer endosomes and allow DNA condensates to release into the cytosol of target cells. Once in the cytosol, crosslinked DNA condensates are proposed to slowly release plasmid DNA following disulfide bond reduction. The central hypothesis to be tested is that increasing DNA condensate stability and controlling the rate of DNA release into the cytosol will prolong the half-life of DNA and produce higher levels of gene expression in vivo. These studies aim to systematically optimize the level of transient gene expression in vivo using a novel chemical mechanism to overcome barriers that currently limit the efficiency of nonviral gene delivery systems.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Targeted Double Stranded mRNA Nanoparticles
  • 批准号:
    9335928
  • 项目类别:
  • 资助金额:
    $30.12万
  • 财政年份:
    2016
  • 负责人:
    KEVIN G RICE
  • 依托单位:
Targeted Double Stranded mRNA Nanoparticles
  • 批准号:
    9523296
  • 项目类别:
  • 资助金额:
    $30.12万
  • 财政年份:
    2016
  • 负责人:
    KEVIN G RICE
  • 依托单位:
Polyacridine Peptide Mediated Gene Targeting
  • 批准号:
    8193314
  • 项目类别:
  • 资助金额:
    $28.39万
  • 财政年份:
    2011
  • 负责人:
    KEVIN G RICE
  • 依托单位:
Polyacridine Peptide Mediated Gene Targeting
  • 批准号:
    8306000
  • 项目类别:
  • 资助金额:
    $28.39万
  • 财政年份:
    2011
  • 负责人:
    KEVIN G RICE
  • 依托单位:
国内基金
海外基金
胰岛素样生长信号介导的肺巨噬细胞和上皮细胞cross-tolk通过核自噬参与慢性气道炎症形成的机制研究
  • 批准号:
    JCZRYB202500229
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
基于NLRP3炎性小体与自噬Cross-talk探讨心康冲剂干预心肌纤维化的机制研究
PKM2琥珀酰化修饰介导癌细胞与血小板间Cross-talk调控胆管癌侵袭转移的研究
  • 批准号:
    JCZRYB202500379
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: